| Name: | Alfuzosin EP Impurity D |
| Catalogue No. | VL259003 |
| CAS No. | 81403-69-2 |
| Molecular Formula | C14H21N5O2.HCL |
| Molecular Weight | 291.35 |
| Status | In-stock |
| IUPAC Name | N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-methylpropane-1,3-diamine hydrochloride |
| Synonyms | Alfuzosin Related Compound D |
| Appearance | Off White Powder |
| Description | Alfuzosin EP Impurity D (CAS No: 81403-69-2) or Alfuzosin USP Related Compound D / Deacylated Impurity is an impurity formed during the synthesis of Alfuzosin that is a quinazoline derivative and an α1-adrenoreceptor blocker used in the treatment of benign prostatic hyperplasia and trial treatment of hypertension. |
| References | Žuvela, Petar, et al. “Assessment of Column Selection Systems Using Partial Least Squares.” Journal of Chromatography A, vol. 1420, Nov. 2015, pp. 74–82, https://doi.org/10.1016/j.chroma.2015.09.085. |
